Compare Comfort Systems USA Inc (FIX) vs Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Comfort Systems USA Inc vs Maravai LifeSciences Holdings Inc. Class A Common Stock — how do they compare? Comfort Systems USA Inc trades at $1,495.05 (market cap $57.25B), while Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M). The key difference: Comfort Systems USA Inc is far larger — about 58.8× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Comfort Systems USA Inc pays a 0.22% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Comfort Systems USA Inc for 42 Days and Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days on average.
| FIX | MRVI | |
|---|---|---|
Market Cap | $57.25B | $972.90M |
Volume | 459,246 | 4,325,710 |
Sector | Industrials | Health |
52-Week High | $2.07K | $9.00 |
52-Week Low | $790.72 | $2.83 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | $55.72B | $1.08B |
Dividend Yield | 0.22% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,626.64, down 0.7% with bearish technical signals but strong fundamentals. The company demonstrates robust earnings momentum with three consecutive quarterly beats and impressive profitability metrics including 55.29% ROE. Recent acquisition of Hunt Electric expands Western electrical scale with $250M in annualized revenue. Technical indicators show bearish momentum with support at $1,611 and resistance at $1,687.
Outlook remains positive with analyst consensus price target of $2,080 representing 28% upside potential. Key opportunities include data center infrastructure demand and modular expansion, while risks involve project execution challenges and market volatility. The stock offers growth exposure to essential AI infrastructure services with strong institutional backing.
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →
